Navigating CSU in Dermatology: Advancing Care with Evolving Strategies - Episode 3
This episode titled “A Practical Diagnostic Workup for CSU,” covers the practical approach to evaluating patients with recurrent hives.
This episode titled “A Practical Diagnostic Workup for CSU,” covers the practical approach to evaluating patients with recurrent hives. Because lesions are often absent during office visits, the panelist frequently asks patients to photograph their hives, calling smartphone images the most valuable diagnostic tool available. When hives are present or documented, the key differential is urticarial vasculitis, distinguished from CSU using three targeted questions: whether lesions burn rather than itch, whether they leave residual discoloration or bruising, and whether an individual lesion persists longer than 24 hours, a question phrased carefully by asking patients to mentally circle one wheal and track whether that specific lesion remains the next day.
The panelist notes that while guidelines recommend baseline labs such as a CBC and ESR, extensive workups are rarely ordered unless atypical features, like fevers, chills, or joint pain, raise suspicion for an autoinflammatory process. IgE testing is similarly dismissed, since neither total IgE levels nor allergen-specific panels are clinically useful in CSU and often introduce misleading red herrings that delay appropriate treatment.
The discussion shifts to quality of life, noting that while urticaria scores lower than atopic dermatitis on itch intensity, it carries a greater overall quality-of-life burden because of its unpredictable, rapidly waxing and waning nature. Many patients avoid scheduling important events for fear of a flare, and the panel notes a clear bidirectional relationship between stress and disease activity. The takeaway is that CSU remains fundamentally a clinical diagnosis built on history and visual recognition, allowing treatment to begin promptly rather than being delayed by unnecessary testing. In the next episode, “The Role of Dermatologists and APPs in Diagnosing CSU,” the panel discusses formal testing for inducible urticaria and why timely recognition by any attentive clinician, regardless of title, is what truly protects patients from years of delayed diagnosis.